Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials (Journal of Clinical Epidemiology, 2022)

(untitled) - Billard, MN; Wildenbeest, J; Bont, LJ; Nair, H; McCracken, JP; Oude Rengerink, K; Marie-Noelle Billard; Bont, L; Campbell, H; Beutels, P; Openshaw, P; Pollard, A; et al.